argenx SE (STU:1AE)
€ 553.6 6 (1.1%) Market Cap: 33.43 Bil Enterprise Value: 30.56 Bil PE Ratio: 0 PB Ratio: 8.44 GF Score: 82/100

argenx SE at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 07:10PM GMT
Release Date Price: €241.9 (+0.67%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Well, good afternoon, everybody, and thank you once again for joining us for the 42nd Annual Cowen Healthcare Conference. It's a great pleasure to moderate the fireside chat today with argenx. I'm Yaron Werber, one of the biotech analysts here at Cowen, and I'm with my colleague, Brendan Smith, also on our team.

So it's a great pleasure to have with us, and they all need no introduction. Tim Van Hauwermeiren, who's the CEO of argenx; Keith Woods, Chief Operating Officer; and Karl Gubitz, who is the Chief Financial Officer.

So gentlemen, thank you for joining us. We appreciate it.

Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director

Thanks for having us, Yaron. As always, it's a pleasure.

Questions & Answers

Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

So we have a lot to talk about. So Tim, I know you've been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot